SPAIN CONGRESS - Aseptic Process
3 years after Annex 1
2nd A3P Spain Congress – Aseptic Process
Following the success of its first edition, the 2nd A3P Spain Congress – Aseptic Processes is establishing itself as a key meeting point for professionals in the pharmaceutical industry committed to excellence in sterile manufacturing.
In a context marked by the implementation of the new GMP Annex 1, which came into force in August 2022, this congress focuses on a particularly relevant moment: analyzing the results achieved after several years of application. It is now time to share real-world experiences, assess the impact of improvement and compliance projects carried out in pharmaceutical facilities, and draw lessons learned that will support continued progress.
The event will bring together renowned experts who will present practical case studies and feedback on their experience with the implementation of Annex 1, addressing both the challenges encountered and the solutions adopted. Attendees will gain an up-to-date perspective on technological, organizational, and operational advances implemented across various industrial sites, with a shared objective: strengthening contamination control and raising quality standards in sterile drug manufacturing.
The program will combine plenary sessions with interactive workshops designed to encourage knowledge exchange, enabling participants to explore specific projects and innovative approaches applied in real-world settings.
As a distinctive feature, each day will conclude with open roundtable discussions aimed at fostering dialogue among professionals, encouraging the sharing of challenges, insights, and best practices. Participants will also be able to propose discussion topics, actively contributing to the identification of effective solutions to current operational issues.
This congress positions itself as a leading platform for the exchange of practical knowledge and the promotion of continuous improvement in aseptic processes within the pharmaceutical industry.
Program
In progress...
